Pharmed Pharmaceutical Pty Ltd has sold a 65% stake to Imperial Holdings Limited
Lenmed Health Pty Ltd has sold a 65% stake in Pharmed Pharmaceutical Pty Ltd to Imperial Holdings Limited for US$10 million.
Pharmed Pharmaceutical Pty Ltd distributes pharmaceutical and other healthcare products in South Africa. The company was founded in 1985 in Overport, Durban by a group of healthcare professionals from previously disadvantaged communities.
Imperial Holdings Limited is a JSE-listed, South African-based international group of companies active in three major areas of mobility: consumer and industrial logistics, vehicle import, distribution, dealerships, retail, rental and aftermarket parts and vehicle-related financial services. The company employs around 52,000 people who generate revenues in excess of US$7.5 billion per year in Africa, Europe, South America, Australia and the USA through five major divisions which operate under separate management structures to enable decentralized entrepreneurial creativity within the group’s clearly defined strategic, capital, budgetary and governance principles.
Lenmed Health is an established black owned hospital group in South Africa, operating multi-specialty hospital facilities in South Africa, Mozambique and Botswana and managing in excess of 1,300 beds.
Oaklins' team in South Africa advised the seller in this transaction.
Talk to the deal team
Related deals
Varsteel, Ltd. has acquired Pacific Steel, Inc.
Pacific Steel, Inc. has been acquired by Varsteel, Ltd.
Learn morePrestige Inhome Care has found a long-term strategic partner
Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.
Learn moreCara Care has been acquired by Mahana Therapeutics
Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.
Learn more